EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Significant histological changes are not rare in indeterminate‐phase chronic hepatitis B patients with hepatitis B e antigen‐negative and normal alanine aminotransferase levels

Deliang Huang, Guangde Zhou, Jinghan Peng, Qinxian Cai, Guojun Li, Hong Yu, Zhibing Zhu, Yuanyuan Chen, Huiyi Lai, Jinyan Jiang, Hong Yu, Jun Chen

iLABMED · 2023

DOI: 10.1002/ila2.24 ↗

Kurz gefasst

Fachartikel in der Zeitschrift iLABMED, 2023. Verfasst von Deliang Huang und 11 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background & Objectives The degree of liver injury in indeterminate chronic hepatitis B (CHB) infection patients with Hepatitis B e antigen(HBeAg)‐negative and persistently normal alanine aminotransferase (PNALT) levels is yet unclear. Therefore, we aimed to assess liver histological changes in such patients by liver biopsy and explore possible predictors.

Methods

Overall, 711 HBeAg‐negative CHB patients with PNALT levels who underwent liver biopsy from January 2017 to June 2022 were included in this retrospective study. The relationships between histological changes and predictors were assessed by smooth curve fitting and multivariate logistic regression analysis models. Data were also analyzed using American Association for the Study of Liver Disease (AASLD) modified alanine aminotransferase (ALT) criteria.

Results

The proportion of significant histological changes in the indeterminate phase was higher than that in the inactive phase (53.97% vs. 41.33%). The adjusted odds ratios (aORs) of significant necroinflammation and histological changes for the indeterminate phase were 2.05 and 1.43, respectively, when compared with the inactive phase by multivariate logistic regression analyses. Significant histological changes in the‐phase were positively associated with age, ALT, Aspartate aminotransferase (AST), Hepatitis B surface antigen (HBsAg), and Hepatitis B virus (HBV) DNA levels but negatively correlated with platelet (PLT) levels. HBV DNA ≥5 log10 U/L and PLT 5 log10 U/L or PLT

Zitieren

APA

Huang, D., Zhou, G., Peng, J., Cai, Q., Li, G., Yu, H., Zhu, Z., Chen, Y., Lai, H., Jiang, J., Yu, H., & Chen, J. (2023). Significant histological changes are not rare in indeterminate‐phase chronic hepatitis B patients with hepatitis B e antigen‐negative and normal alanine aminotransferase levels. iLABMED. https://doi.org/10.1002/ila2.24

Vancouver

Huang D, Zhou G, Peng J, Cai Q, Li G, Yu H, et al. Significant histological changes are not rare in indeterminate‐phase chronic hepatitis B patients with hepatitis B e antigen‐negative and normal alanine aminotransferase levels. iLABMED. 2023. doi:10.1002/ila2.24

BibTeX
@article{Huang2023,
  author = {Huang, Deliang and Zhou, Guangde and Peng, Jinghan and Cai, Qinxian and Li, Guojun and Yu, Hong and Zhu, Zhibing and Chen, Yuanyuan and Lai, Huiyi and Jiang, Jinyan and Yu, Hong and Chen, Jun},
  title = {Significant histological changes are not rare in indeterminate‐phase chronic hepatitis B patients with hepatitis B e antigen‐negative and normal alanine aminotransferase levels},
  journal = {iLABMED},
  year = {2023},
  doi = {10.1002/ila2.24}
}
Kostenlos starten →